Relationship between dyslipidemia, c-reactive protein and serological evidence of Chlamydia pneumoniae in Turkish patients with coronary artery diseases

New Microbiologica

Volumn 27, Issue 3, 2004, Pages 229-234

  Turkoglu, C ^a   Sonmez, E ^a   Aydinli, A ^b  

^a KADIR HAS UNIVERSITY   (Turkey)

^b FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

Author keywords

C. Pneumoniae; Coronary artery disease; CRP; Dyslipidemia

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; MEASUREMENT; POPULATION RESEARCH; RISK; SEROLOGY;

ADULT; AGED; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TRIGLYCERIDES; TURKEY;

CHLAMYDIA; CHLAMYDOPHILA; CHLAMYDOPHILA PNEUMONIAE;

EID: 11444260159     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ABDELMOUTTALEB, I., DANCHIN, N., ILARDA, C., AIMENO-GASTIN, I., ANGIOL, M., LOZNIEWSKI, A., LOUBINOUX, J., LEFAOU, A., GUEANT, J. L. (1999). CRP and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. American Heart Journal, 137 (2), 346-351.
2. ARBUSTINI, E., MORBINI, P., BELLO, B.D., PRATI, F., SPESCCHIA, G. (1999). From plaque biology to clinical setting. American Heart Journal, 138, 55-60.
3. ARMITTAGE, G.C. (2000). Periodontal infections and cardiovascular disease- how strong is the association? Oral Diseases, 6 (6), 335-350.
4. EPSTEIN, S.E., ZHAU, Y. F., ZHU, J. (1999). Infection and atherosclerosis: emerging mechanistic paradigms. Circulation, 100, 20-28.
5. ESPINOLA-KLEIN, C., RUPPRECHT, H.J., BLANKENBERG, S., BICKEL, C., KOPP, H., RIPPIN, G., VICTOR, A., HAFNER, G., SCHLUMBERGER, W., MEYER, J., ATHEROG INVESTIGATORS. (2002). Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation, 105(1), 15-21.
6. FRIEDEWALD, N.T., LEVY, R.I., FREDICKSON, D.S. (1972). Estimation of the concantration of low-density lipoprotein cholesterol in plasma, without use the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
7. GRAYSTON, J.T., KUO, C.C., CAMPELL, L.A., BENDITT, E.P. (1993). Chlamydia pneumoniae strain TWAR, and atherosclerosis. Eurepean Heart Journal, 14, 66-71.
8. HAVERKATE, F., THOMPSON, S.G., PYKE, S.D.M., GALLIMORE, J.R., PEPYS, M.B. (1997). Production of CRP and risk of coronary events in stable and unstable angina. Lancet, 349, 462-466.
9. JAHN, J., HELLMANN, I., KOTHE, H., MAASS, M., DALHOFF, K., KATUS, H.A. (2001). Infection hypothesis of coronary heart disease. Wien Medical Wochenschr, 151 (24), 594-599.
10. KOSAKA, C., HARA, K., KOMIJAMA, Y., TAKAHASKI, H. (2000). Possible role of chronic infection with C. pneumoniae in Japanase patients with acute myocardial infarction. Japanase Circulation, 64 (11), 819-824.
11. LAURILA, A., BLOIGU, A., NAYHA, S., HASSI, J., LEINONEN, M., SAIKKU, P. (1997). C. pneumoniae antibodies and serum lipids in Finnish men: cross sectional study. British Medical Journal, 314, 1456-1457.
12. LAURILA, A., BLOIGU, A., NAYHA, S., HASSI, J., LEINONEN, M., SAIKKU, P. (1997) Chronic C. pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arteriosclerosis Thrombosis Vascular Biology, 17, 2910-2913.
13. LIBBY, P., EGAN, D., SKARLATOS, S. (1997). Roles of infectious agents in atherosclerosis and restenosis. Circulation, 96, 4095-4103.
14. MARCH, F., LOVIS, C., GASPOZ, J.M., UNGER, P.F., BOUILLIE, M., URBAN, P. (1997). CRP as a marker for acute coronary syndroms. Eurepean Hearth Journal, 18, 1897-1902.
15. MURRAY, L.J., O'REILLY, D.P.J., ONG, G.M.L., EVANS, A.E., BAMFORD, K.B. (1999). C. pneumoniae antibodies are associated with an atherogenic lipid profile. Heart, 81, 239-244.
16. PIENIAZEK, P., KAREZEWSKA, E., STEPIEN, E., TRACZ, W., KONTWEK, S.J. (2001). Incidence of C. pneumoniae infection in patients with coronary artery disease subjected to angioplasty or bypass surgery. Medical Science Monitorisation, 7 (5), 995-1001.
17. PRASAD, A., ZHU, J., HALCOX, J.P., WACLAWIW, M.A., EPSTEIN, S.E., QUYYUMI A.A. (2002). Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation, 106 (2), 184-190.
18. RAMIREZ, J.A. (1996). Isolation of C. pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Annals Internal Medicine, 125, 979-982.
19. RICHMOND, W. (1973). Preparation and properties of a cholesterol oxidase from Nocardia sp. And its application to the enzymatic assay of total cholesterol in serum. Clinical Chemistry, 19, 1350-1356.
20. SAIKKU, P., LEINONEN, M., MATTIKA, K., EKMAN, M.R., NIEMINEN, M.S., MAHELA, P.H., HUTTENEN, J.K., VALTANEN, V. (1998). Serologic evidence of an association of a novel Chlamydia, TWAR with chronic coronary heart disease in acute myocardial infarction. Lancet, 2, 983-986.
21. SAIKKU, P., LEINONEN, M., TESKANEN, L., LINNAMEKI, E., EKMAN, M.R., MANNIEV, V., MANTARRI, M., FRICK, M.H., HUTTENON, J.K. (1992). Chronic C. pneumoniae infection as a risk factor for coronary heart disease in Helsinki Heart Study. Annals Internal Medicine, 116, 273-278.
22. SAIKKU, P. (1996). C. pneumoniae and cardiovascular diseases. Clinical Microbiolology and Infection, 1 (1), 19-22.
23. SCHUMACHER, A., LERKERAD, A.B., SELJEFLOT, I., SOMMERVOLL, L., HOLME, I., OTTERSTAD, J.E., ARNESEN, H. (2001). Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. Jounal of Clinical Microbiology, 5 (39), 1859-1864.
24. SCHUMACHER, A., SELJEFLOT, I., LERKERAD, A.B., SOMMERVOLL, L., OTTERSTAD, J.E., ARNESEN, H. (2002). Does infection with C. pneumoniae and/or H. pylori increase the expression of endothelial cell adhesion molecules in humans? Clinical Microbiology and Infection, 8 (10), 654-661.
25. SMIEJA, M., CRONIN, I., LEVINE, M., GOLDSMITH, C. H., YUSUF, S., MAHONY, J. B. (2001). Previous exposure to C. pneumoniae , H. pylori, and other infections in Canadian patients with ischemic heart disease. Canadian Journal of Cardiolology, 17 (3), 270-276.
26. SMIEJA, M., GNARPE, J., LONN, E., GNARPE, H., OLSSON, G., YI, Q., DZARIK, V., MCQUEEN, M., YUSUF, S., HEART OUTCOMES PREVENTION EVALUATION (HOPE), STUDY, INVESTIGATORS. (2003). Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation, 107 (2), 251-257.
27. SOMMERSCHILD, H.T. (2001). Is infection a pathogenic factor in coronary heart disease? Ugeskr Laeger, 163 (13), 1834-1842.
28. STAVROPOULOS, W. S., CROUCH, R.D. (1974). A new colorimetric procedure for the determination of serum glycerides. Clinical Chemistry, 20, 857.
29. WARNICK, G.R., BENDERSON, J.M., ALBERS, J.J. (1982). Quantitation of high density lipoprotein sub-classes after separation after by dextran sulfate and magnesium precipitation. Clinical Chemistry, 28, 1574.